Artelo Biosciences, Inc.

Pharmaceutical company · Solana Beach, California, United States · Nasdaq: ARTL

Artelo Biosciences, Inc. is a pharmaceutical company headquartered in Solana Beach, California, United States. Its shares trade on Nasdaq under the ticker ARTL. It has reported private securities offerings to the US SEC, most recently $11 million sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Artelo Biosciences at a glance

Typepharmaceutical company
HeadquartersSolana Beach, California, United States
Stock listingNasdaq: ARTL
SEC industryPharmaceutical Preparations
SEC CIK1621221

What does Artelo Biosciences do?

Private fundraising reported to the SEC

15 Form D notices; the most recent reported $11 million sold (2026).

Frequently asked questions about Artelo Biosciences

Where is Artelo Biosciences headquartered?

Artelo Biosciences, Inc. is headquartered in Solana Beach, California, United States.

What does Artelo Biosciences do?

Artelo Biosciences, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Artelo Biosciences a public company?

Yes. Artelo Biosciences, Inc. trades on Nasdaq under the ticker ARTL.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences